Development and optimization of a new hybrid chitosan-grafted graphene oxide/magnetic nanoparticle system for theranostic applications

Warning The system is temporarily closed to updates for reporting purpose.

Baktash, M. Saviz and Zarrabi, Ali and Avazverdi, Ehsan and Reis, Nuno Miguel (2021) Development and optimization of a new hybrid chitosan-grafted graphene oxide/magnetic nanoparticle system for theranostic applications. Journal of Molecular Liquids, 322 . ISSN 0167-7322 (Print) 1873-3166 (Online)

Full text not available from this repository. (Request a copy)

Abstract

There is currently a great demand especially in cancer treatment for transformative theranostic technologies combining imaging with drug delivery. This study reports the design and optimization of a hybrid theranostic nano-system combining the imaging capabilities of magnetic nanoparticles (MNPs) with the great potential of chitosan-grafted graphene oxide (GO) as a pH-sensitive smart nano-carrier, using different molecular weights and concentrations of chitosan. The loading and release behavior, biocompatibility, and magnetic properties of the MNP/GO/chitosan nano-system were experimentaly evaluated with a chemottherapy drug, Doxorubicin through a range of analytical methods. Increased pH resulted in a reduction in the rate of doxorubicin release, suggesting the formation of hydrogen bonds and the physical prevention of collapsed chitosan chains. In addition, a decrease in chitosan molecular weight, and an increase in concentration reduced the doxorubicin loading in around 24% yet a decrease in molecular weight increased the released amount in more than 200%. This has been related to fewer hydrogen binding and more contribution of π-π stacking in doxorubicin-chitosan interactions. The T2 contrast efficacy increased by grafting MNP/GO with high molecular weight chitosan due to the better surface coverage. Cytotoxicity assays with healthy L929 cell lines revealed high biocompatibility of MNP/GO/chitosan nano-system, suggesting chitosan prevents GO contact with the cell membrane. Further assays carried out with cancer cells MCF7 with MNP/GO/chitosan loaded with doxorubicin showed improved performance for MNP/GO grafted with low molecular weight chitosan. On the overall, the hybrid MNP/GO grafted with high molecular weight chitosan at 6.0 g/dl showed optimal properties for theranostic applications.
Item Type: Article
Uncontrolled Keywords: Chitosan; Doxorubicin; Drug delivery; Graphene oxide; Magnetic nanoparticles; Theranostic
Divisions: Sabancı University Nanotechnology Research and Application Center
Depositing User: Ali Zarrabi
Date Deposited: 19 Aug 2022 14:43
Last Modified: 19 Aug 2022 14:43
URI: https://research.sabanciuniv.edu/id/eprint/43252

Actions (login required)

View Item
View Item